Literature DB >> 36035551

Pre-Exposure Prophylaxis for HIV in Primary Care and Beyond.

Theresa Drallmeier1, Ashley Meyr2.   

Abstract

HIV pre-exposure prophylaxis (PrEP) is antiretroviral medication used to prevent HIV in patients at increased risk of acquisition due to sexual practices or intravenous drug use. Despite strong evidence of efficacy and safety, PrEP is currently underutilized in the United States. Initial testing includes HIV, hepatitis B, and renal function. There are currently two oral medications approved for daily use within the U.S.; regular monitoring for HIV and renal dysfunction is required with both medications. Copyright 2022 by the Missouri State Medical Association.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36035551      PMCID: PMC9324708     

Source DB:  PubMed          Journal:  Mo Med        ISSN: 0026-6620


  27 in total

1.  United States family planning providers' knowledge of and attitudes towards preexposure prophylaxis for HIV prevention: a national survey.

Authors:  Dominika Seidman; Kimberly Carlson; Shannon Weber; Jacki Witt; Patricia J Kelly
Journal:  Contraception       Date:  2016-01-06       Impact factor: 3.375

2.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Authors:  Robert M Grant; Javier R Lama; Peter L Anderson; Vanessa McMahan; Albert Y Liu; Lorena Vargas; Pedro Goicochea; Martín Casapía; Juan Vicente Guanira-Carranza; Maria E Ramirez-Cardich; Orlando Montoya-Herrera; Telmo Fernández; Valdilea G Veloso; Susan P Buchbinder; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Kenneth H Mayer; Esper Georges Kallás; K Rivet Amico; Kathleen Mulligan; Lane R Bushman; Robert J Hance; Carmela Ganoza; Patricia Defechereux; Brian Postle; Furong Wang; J Jeff McConnell; Jia-Hua Zheng; Jeanny Lee; James F Rooney; Howard S Jaffe; Ana I Martinez; David N Burns; David V Glidden
Journal:  N Engl J Med       Date:  2010-11-23       Impact factor: 91.245

3.  A Translational Pharmacology Approach to Predicting Outcomes of Preexposure Prophylaxis Against HIV in Men and Women Using Tenofovir Disoproxil Fumarate With or Without Emtricitabine.

Authors:  Mackenzie L Cottrell; Kuo H Yang; Heather M A Prince; Craig Sykes; Nicole White; Stephanie Malone; Evan S Dellon; Ryan D Madanick; Nicholas J Shaheen; Michael G Hudgens; Jacob Wulff; Kristine B Patterson; Julie A E Nelson; Angela D M Kashuba
Journal:  J Infect Dis       Date:  2016-02-24       Impact factor: 5.226

4.  Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women.

Authors:  Jared M Baeten; Thesla Palanee-Phillips; Elizabeth R Brown; Katie Schwartz; Lydia E Soto-Torres; Vaneshree Govender; Nyaradzo M Mgodi; Flavia Matovu Kiweewa; Gonasagrie Nair; Felix Mhlanga; Samantha Siva; Linda-Gail Bekker; Nitesha Jeenarain; Zakir Gaffoor; Francis Martinson; Bonus Makanani; Arendevi Pather; Logashvari Naidoo; Marla Husnik; Barbra A Richardson; Urvi M Parikh; John W Mellors; Mark A Marzinke; Craig W Hendrix; Ariane van der Straten; Gita Ramjee; Zvavahera M Chirenje; Clemensia Nakabiito; Taha E Taha; Judith Jones; Ashley Mayo; Rachel Scheckter; Jennifer Berthiaume; Edward Livant; Cindy Jacobson; Patrick Ndase; Rhonda White; Karen Patterson; Donna Germuga; Beth Galaska; Katherine Bunge; Devika Singh; Daniel W Szydlo; Elizabeth T Montgomery; Barbara S Mensch; Kristine Torjesen; Cynthia I Grossman; Nahida Chakhtoura; Annalene Nel; Zeda Rosenberg; Ian McGowan; Sharon Hillier
Journal:  N Engl J Med       Date:  2016-02-22       Impact factor: 91.245

5.  On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.

Authors:  Jean-Michel Molina; Catherine Capitant; Bruno Spire; Gilles Pialoux; Laurent Cotte; Isabelle Charreau; Cecile Tremblay; Jean-Marie Le Gall; Eric Cua; Armelle Pasquet; François Raffi; Claire Pintado; Christian Chidiac; Julie Chas; Pierre Charbonneau; Constance Delaugerre; Marie Suzan-Monti; Benedicte Loze; Julien Fonsart; Gilles Peytavin; Antoine Cheret; Julie Timsit; Gabriel Girard; Nicolas Lorente; Marie Préau; James F Rooney; Mark A Wainberg; David Thompson; Willy Rozenbaum; Veronique Doré; Lucie Marchand; Marie-Christine Simon; Nicolas Etien; Jean-Pierre Aboulker; Laurence Meyer; Jean-François Delfraissy
Journal:  N Engl J Med       Date:  2015-12-01       Impact factor: 91.245

6.  Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial.

Authors:  Onyema Ogbuagu; Peter J Ruane; Daniel Podzamczer; Laura C Salazar; Keith Henry; David M Asmuth; David Wohl; Richard Gilson; Yongwu Shao; Ramin Ebrahimi; Stephanie Cox; Alexander Kintu; Christoph Carter; Moupali Das; Jared M Baeten; Diana M Brainard; Gary Whitlock; Jason M Brunetta; Gitte Kronborg; Christoph D Spinner
Journal:  Lancet HIV       Date:  2021-07       Impact factor: 12.767

7.  Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women.

Authors:  Annalene Nel; Neliëtte van Niekerk; Saidi Kapiga; Linda-Gail Bekker; Cynthia Gama; Katherine Gill; Anatoli Kamali; Philip Kotze; Cheryl Louw; Zonke Mabude; Nokuthula Miti; Sylvia Kusemererwa; Hugo Tempelman; Hannelie Carstens; Brid Devlin; Michelle Isaacs; Mariëtte Malherbe; Winel Mans; Jeremy Nuttall; Marisa Russell; Smangaliso Ntshele; Marlie Smit; Leonard Solai; Patrick Spence; John Steytler; Kathleen Windle; Maarten Borremans; Sophie Resseler; Jens Van Roey; Wim Parys; Tony Vangeneugden; Ben Van Baelen; Zeda Rosenberg
Journal:  N Engl J Med       Date:  2016-12-01       Impact factor: 91.245

8.  HIV Infection and HIV-Associated Behaviors Among Persons Who Inject Drugs - 20 Cities, United States, 2015.

Authors:  Janet C Burnett; Dita Broz; Michael W Spiller; Cyprian Wejnert; Gabriela Paz-Bailey
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-01-12       Impact factor: 17.586

9.  HIV Preexposure Prophylaxis, by Race and Ethnicity - United States, 2014-2016.

Authors:  Ya-Lin A Huang; Weiming Zhu; Dawn K Smith; Norma Harris; Karen W Hoover
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-10-19       Impact factor: 17.586

10.  Substance Use and Adherence to HIV Preexposure Prophylaxis for Men Who Have Sex with Men1.

Authors:  Martin Hoenigl; Sonia Jain; David Moore; Deborah Collins; Xiaoying Sun; Peter L Anderson; Katya Corado; Jill S Blumenthal; Eric S Daar; Joel Milam; Michael P Dubé; Sheldon Morris
Journal:  Emerg Infect Dis       Date:  2018-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.